development of medical devices
monitoring PoC medical device
quality of eye health care Ocular diseases
health care area
quantification of biomarkers
measure biomarkers
diagnosis of diseases
point of care
use of medical devices able
ophthalmology units
ophthalmology applications
health systems
Clinical validation
eye therapy
Dry Eye
patient vision care
ocular surface diseases
market introduction
easy introduction
French pharmaceutical company
standard clinical protocols
new diagnostic
sales of pharmaceutical
economic growth
economic issues
Spanish company
strategic development
availability of easy
tear fluids
Tear Monitor
present project
growing market opportunity
biotech products
number
production
biomarker discovery
frequency of sick leave
significant reduction of overcrowding
human samples
non-invasive method
respective expertises
companies
disability
visual problems
distribution
OSDs
Bioftalmik
inflammation
international expansion
collaborative partnership
objective manner
complementary synergism
base
Horus Pharma
doctorâ€™s office
ageing population
immediate future
European SMEs
treatments effectiveness
objectives
purpose
tears